by Inteliquet | Feb 24, 2020 | cancer, Clinical Trials, healthcare, Oncology, patients
Scott Kratz recently joined the Global Leadership Panel of Fight Cancer Global (FCG). Scott joined FCG to be a resource and advise in the area of clinical trials and patient recruitment. Here is background on FCG: They are fighting cancer by working to transform the...
by Robert Minicucci | Dec 16, 2019 | clinical research, CROs, FOCR, lung cancer, NSCLC, Oncology, patients, Pharma, RCTs, RWD/RWE, Uncategorized
What if real-world data (RWD) sources can increase the speed of getting therapies to market? Instead of waiting five years for a clinical trial to be designed, enrolled, and completed … what if we could do...
by Robert Minicucci | Oct 12, 2019 | Clinical Trials, disruptive technology, DPHARM, life sciences, Oncology, patient centric, patients, Pharma, Uncategorized
“Too much cost. Too much time. Too much uncertainty,” were themes heard over and over at 2019’s DPharm: Disruptive Innovations Conference in Boston. The two-day gathering highlights the promises and challenges of bringing innovation to drug development, so...
by Robert Minicucci | Jun 25, 2019 | ASCO, Clinical Trials, CROs, Oncology, patients, Pharma, Uncategorized
When asked the question of how Inteliquet can help clinical trials succeed, CEO Carla Balch did not hesitate. Carla said Inteliquet, as a technology innovator, is capable of “Screening Every Patient, Every Night, for Every Trial.” She also noted that the...
by Inteliquet | Jun 11, 2019 | clinical data, Clinical Trials, Oncology, patients, Pharma
At Inteliquet, Jim Reddy works with organizations as a consultant for workflow and data analysis. He has been working with hospitals and physician groups for a number of medical specialties for the past 28 years, focusing on clinical operations, data quality and...
by Inteliquet | May 15, 2019 | clinical data, clinical research, Clinical Trials, CROs, Oncology, patients
Linda is Director of Clinical Services at Inteliquet. She has 25+ years of nursing, clinical research, training, and leadership experience. We discussed her passion for clinical research, how she discovered it, and why she came back to it. —- What drew you to...
